Welcome!

News Feed Item

Spinal Cord Injury Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Spinal Cord Injury Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02280945/Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

Spinal Cord Injury Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Spinal Cord Injury Global Clinical Trials Review, H2, 2014" provides data on the Spinal Cord Injury clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spinal Cord Injury. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spinal Cord Injury. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Spinal Cord Injury 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Spinal Cord Injury 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Spinal Cord Injury Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Spinal Cord Injury 34
May 19, 2014: StemCells Provides Update on Its Phase I/II Study in Spinal Cord Injury 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Acorda Therapeutics, Inc. 36
Clinical Trial Overview of Acorda Therapeutics, Inc. 36
Allergan, Inc. 37
Clinical Trial Overview of Allergan, Inc. 37
Stem Cell Sciences UK Ltd 38
Clinical Trial Overview of Stem Cell Sciences UK Ltd 38
Neuralstem, Inc. 39
Clinical Trial Overview of Neuralstem, Inc. 39
BioAxone BioSciences Inc. 40
Clinical Trial Overview of BioAxone BioSciences Inc. 40
AOSpine International 41
Clinical Trial Overview of AOSpine International 41
K-Stemcell Co., Ltd. 42
Clinical Trial Overview of K-Stemcell Co., Ltd. 42
Daiichi Sankyo Company, Limited 43
Clinical Trial Overview of Daiichi Sankyo Company, Limited 43
Bayer AG 44
Clinical Trial Overview of Bayer AG 44
Clinical Trial Overview of Top Institutes / Government 45
U.S. Department of Veterans Affairs 45
Clinical Trial Overview of U.S. Department of Veterans Affairs 45
University of Miami 48
Clinical Trial Overview of University of Miami 48
University of Washington 49
Clinical Trial Overview of University of Washington 49
National Institute of Neurological Disorders and Stroke 50
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 50
University of British Columbia 51
Clinical Trial Overview of University of British Columbia 51
Eunice Kennedy Shriver National Institute of Child Health and Human Development 52
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 52
China Spinal Cord Injury Network 53
Clinical Trial Overview of China Spinal Cord Injury Network 53
National Taiwan University Hospital 54
Clinical Trial Overview of National Taiwan University Hospital 54
James J. Peters Veterans Affairs Medical Center 55
Clinical Trial Overview of James J. Peters Veterans Affairs Medical Center 55
University of California, Irvine 56
Clinical Trial Overview of University of California, Irvine 56
Five Key Clinical Profiles 57
Appendix 104
Abbreviations 104
Definitions 104
Research Methodology 105
Secondary Research 105
About GlobalData 106
Contact Us 106
Disclaimer 106
Source 106

List of Tables

Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region, 2014* 7
Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Spinal Cord Injury Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spinal Cord Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spinal Cord Injury Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Spinal Cord Injury Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26
Spinal Cord Injury Therapeutics, Global, Terminated Clinical Trials, 2014* 27
Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 35
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Acorda Therapeutics, Inc., 2014* 36
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2014* 37
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Stem Cell Sciences UK Ltd, 2014* 38
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Neuralstem, Inc., 2014* 39
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by BioAxone BioSciences Inc., 2014* 40
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by AOSpine International, 2014* 41
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by K-Stemcell Co., Ltd., 2014* 42
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 43
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 44
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 45
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 48
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Washington, 2014* 49
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 50
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of British Columbia, 2014* 51
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 52
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by China Spinal Cord Injury Network, 2014* 53
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 54
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by James J. Peters Veterans Affairs Medical Center, 2014* 55
Spinal Cord Injury Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Irvine, 2014* 56

List of Figures

Spinal Cord Injury Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Spinal Cord Injury Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Spinal Cord Injury Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Spinal Cord Injury Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Spinal Cord Injury Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Spinal Cord Injury Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Spinal Cord Injury Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Spinal Cord Injury Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Spinal Cord Injury to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Spinal Cord Injury Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Spinal Cord Injury Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Spinal Cord Injury Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Spinal Cord Injury Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Spinal Cord Injury Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Spinal Cord Injury Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Spinal Cord Injury Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Spinal Cord Injury Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Spinal Cord Injury Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Spinal Cord Injury Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 105

To order this report: Spinal Cord Injury Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02280945/Spinal-Cord-Injury-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
DXWorldEXPO LLC, the producer of the world's most influential technology conferences and trade shows has announced the 22nd International CloudEXPO | DXWorldEXPO "Early Bird Registration" is now open. Register for Full Conference "Gold Pass" ▸ Here (Expo Hall ▸ Here)
The now mainstream platform changes stemming from the first Internet boom brought many changes but didn’t really change the basic relationship between servers and the applications running on them. In fact, that was sort of the point. In his session at 18th Cloud Expo, Gordon Haff, senior cloud strategy marketing and evangelism manager at Red Hat, will discuss how today’s workloads require a new model and a new platform for development and execution. The platform must handle a wide range of rec...
Bill Schmarzo, author of "Big Data: Understanding How Data Powers Big Business" and "Big Data MBA: Driving Business Strategies with Data Science" is responsible for guiding the technology strategy within Hitachi Vantara for IoT and Analytics. Bill brings a balanced business-technology approach that focuses on business outcomes to drive data, analytics and technology decisions that underpin an organization's digital transformation strategy.
Rodrigo Coutinho is part of OutSystems' founders' team and currently the Head of Product Design. He provides a cross-functional role where he supports Product Management in defining the positioning and direction of the Agile Platform, while at the same time promoting model-based development and new techniques to deliver applications in the cloud.
CloudEXPO New York 2018, colocated with DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City and will bring together Cloud Computing, FinTech and Blockchain, Digital Transformation, Big Data, Internet of Things, DevOps, AI, Machine Learning and WebRTC to one location.
"We began as LinuxAcademy.com about five years ago as a very small outfit. Since then we've transitioned into more of a DevOps training company - the technologies and the tooling around DevOps," explained Doug Vanderweide, an instructor at Linux Academy, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
DevOpsSummit New York 2018, colocated with CloudEXPO | DXWorldEXPO New York 2018 will be held November 11-13, 2018, in New York City. Digital Transformation (DX) is a major focus with the introduction of DXWorldEXPO within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term.
IoT is rapidly becoming mainstream as more and more investments are made into the platforms and technology. As this movement continues to expand and gain momentum it creates a massive wall of noise that can be difficult to sift through. Unfortunately, this inevitably makes IoT less approachable for people to get started with and can hamper efforts to integrate this key technology into your own portfolio. There are so many connected products already in place today with many hundreds more on the h...
They say multi-cloud is coming, but organizations are leveraging multiple clouds already. According to a study by 451 Research, only 21% of organizations were using a single cloud. If you've found yourself unprepared for the barrage of cloud services introduced in your organization, you will need to change your approach to engaging with the business and engaging with vendors. Look at technologies that are on the way and work with the internal players involved to have a plan in place when the ine...
The revocation of Safe Harbor has radically affected data sovereignty strategy in the cloud. In his session at 17th Cloud Expo, Jeff Miller, Product Management at Cavirin Systems, discussed how to assess these changes across your own cloud strategy, and how you can mitigate risks previously covered under the agreement.
Traditional on-premises data centers have long been the domain of modern data platforms like Apache Hadoop, meaning companies who build their business on public cloud were challenged to run Big Data processing and analytics at scale. But recent advancements in Hadoop performance, security, and most importantly cloud-native integrations, are giving organizations the ability to truly gain value from all their data. In his session at 19th Cloud Expo, David Tishgart, Director of Product Marketing ...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
Machine Learning helps make complex systems more efficient. By applying advanced Machine Learning techniques such as Cognitive Fingerprinting, wind project operators can utilize these tools to learn from collected data, detect regular patterns, and optimize their own operations. In his session at 18th Cloud Expo, Stuart Gillen, Director of Business Development at SparkCognition, discussed how research has demonstrated the value of Machine Learning in delivering next generation analytics to impr...
"DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great team at @DevOpsSUMMIT and CloudEXPO tell the world how they can leverage this emerging disruptive trend."
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform and how we integrate our thinking to solve complicated problems. In his session at 19th Cloud Expo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and sh...